BRAF and neoplasm: Data for unique BRAF mutants may be obtained from case reports or case series of patients with advanced melanomas, as well as other tumor entities for which BRAF mutations have been described, such as thyroid, colorectal, or non-small cell lung cancer (NSCLC) [14••].